Other studies have shown that under hypoxia, IL-17A can up-regulate the expression of MMP-2 and MMP-9 by activating the NF-κB/HIF-1α pathway and promoting the migration and invasion of RA-FLS (71). Here, IL17A is linked to rheumatoid arthritis.